TB-500 (Thymosin β4 fragment)

TB-500: Structure and Where It Comes From

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

TB-500 is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, seven residues taken from positions 17 to 23 of thymosin beta-4 with an acetylated N-terminus. At 889.0 Da it is small, highly polar, and carries no cysteine, methionine or aromatic residue.

Key facts

Sequence
Ac-LKKTETQ
Residues
7
Molecular weight
889.0 Da
Formula
C38H68N10O14
Origin
Residues 17-23 of thymosin beta-4
N-terminus
Acetylated (+42.0 Da)
Cys / Met / aromatic
None of any

An internal fragment, not a terminal one

TB-500 comes from the middle of its parent, which is unusual among research peptides. Most fragments in circulation are N-terminal or C-terminal pieces. Taking an internal segment means both ends are artificial: the natural sequence continues in both directions in the parent, and the fragment's termini exist only because synthesis stopped there.

Why the N-terminus is acetylated

An internal residue has no free alpha-amino group. It is engaged in a peptide bond with the residue before it. Synthesising the fragment alone creates a free amine that does not exist in the protein, carrying a positive charge that is an artefact of the excision. Acetylation caps it, restoring something closer to the parent's electrostatics and incidentally slowing aminopeptidase attack.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The composition

Two lysines, one glutamate, two threonines, one leucine, one glutamine. Strongly polar throughout with no hydrophobic core, and net positively charged at physiological pH. There is no cysteine, no methionine and no aromatic residue, which removes disulfide chemistry, methionine oxidation, and the possibility of quantification by absorbance at 280 nm respectively.

What the structure implies

A short, highly charged, aromatic-free peptide will be very water-soluble and conformationally flexible. It will adsorb readily to surfaces, which matters for small quantities. And it offers no convenient spectroscopic handle, so concentration must be established by other means.

How the parent differs

Thymosin beta-4 at 43 residues contains methionine and other residues absent from the fragment, and behaves quite differently in handling as well as biology. Guidance written for one does not automatically apply to the other, which is a recurring theme in this category and a direct consequence of two products sharing a name.

Frequently asked questions

Is TB-500 an N-terminal fragment?

No. It is internal, from residues 17 to 23. Both its termini are artefacts of synthesis rather than features of the parent.

Why does acetylation matter?

It caps a free amine that does not exist in the protein, restoring closer electrostatics and slowing aminopeptidase degradation.

Can TB-500 be quantified at 280 nm?

No. There is no tryptophan, tyrosine or phenylalanine, so it has no usable absorbance there.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.